BV
Bioventus Inc.
BVS · NASDAQ
$12.98 -2.26% (-$0.30)
1M -8.98%
Market Cap $884.8M
P/E Ratio 16.25x
Div. Yield -
ROE 28.39%
Bulios Fair Price
$7.24
44.2% downside
Trenutna cena
$12.98
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BVS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
77 /100
Cheap EV/EBITDA 12.06x
P/S 1.52x
P/B 3.88x
Growth
30 /100
Declining Book val. growth 17.28%
Rev. growth 3.52%
FCF growth N/A
Profitability
74 /100
Strong Net margin 9.36%
Op. margin 10.63%
FCF margin 16.20%
Quality
89 /100
Excellent ROE 28.39%
ROA 8.09%
Asset turnover 0.86x
Debt
51 /100
Moderate Current ratio 1.69x
Int. coverage 2.94x
Net debt/EBITDA 2.52x
Stability
58 /100
Moderate Rev. volatility 7.13%
EPS volatility 79.84%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BVS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Claypoole
Employees
950
Headquarters
Durham
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report